Optical imaging method and system for characterization and mapping of tissue lesions
The present invention provides a method and an apparatus for the in vivo, non-invasive, early detection of alterations and mapping of the grade of these alterations, caused in the biochemical and/or in the functional characteristics of epithelial tissues during the development of tissue atypias, dysplasias, neoplasias and cancers. The method is based, at least in part, on the simultaneous measurement of the spatial, temporal and spectral alterations in the characteristics of the light that is re-emitted from the tissue under examination, as a result of a combined tissue excitation with light and special chemical agents. The topical or systematic administration of these agents result in an evanescent contrast enhancement between normal and abnormal areas of tissue. The apparatus enables the capturing of temporally successive imaging in one or more spectral bands simultaneously. Based on the measured data, the characteristic curves that express the agent-tissue interaction kinetics, as well as numerical parameters derived from these data, are determined in any spatial point of the examined area. Mapping and characterization of the lesion, are based on these parameters.
1. An optical imaging method for diagnosing pathological tissue in vivo, comprising the steps of:
administering a pathology differentiating agent to an examination area of a tissue sample, wherein said pathology differentiating agent provokes a transient alteration in an optical property of said tissue sample;
exposing the examination area of the tissue sample to optical radiation;
substantially eliminating a relative motion between the tissue sample and an optical head in order to substantially align the spatial points of the examination area of the tissue sample and the optical head;
measuring the intensity of light re-emitted from the examination area of the tissue sample with the optical head at various time instances from a start time t 0 until at least a substantial ending time of said transient alteration;
for each XY spatial point of the examination area of the tissue sample, computing data representative of the intensity of the light (PV XY ) re-emitted from the XY spatial point in the examination area of the tissue sample versus time to express the kinetics of the provoked alterations in tissue optical properties from the examination area of the tissue sample;
calculating at least one dynamic optical property of the tissue in the examination area from the data corresponding to a time extending from about the start time (t 0 ) to at least a relaxation time (t rel ), wherein the relaxation time corresponds to a time at which the intensity of the light attains the value of A/e, where A is a maximum pixel value and e is the base of Neper logarithms; and
generating an image of the kinetics of the phenomenon (KI) to express a spatial distribution of the at least one dynamic optical property, the image having pixel values corresponding to each spatial point of the examination area of the tissue sample,
wherein the image provides a visual representation for evaluation of the intensity and extent of the provoked transient alteration to diagnose pathological tissue in vivo.
2. The method of claim 1 , wherein said re-emitted light is the light scattered from the tissue.
3. The method of claim 1 , wherein said tissue is exposed to broadband optical radiation.
4. The method of claim 1 , wherein said tissue is exposed to optical radiation of narrower spectral width than the width of the emission spectral range of a light emitted by illumination light source.
5. The method of claim 1 , wherein the light re-emitted from the examination area of the tissue sample comprises a set of spectral bands, and wherein the intensity of the light re-emitted from the examination area of the tissue sample is measured simultaneously in two or more of the spectral bands, corresponding to a sub-set of the set of the spectral bands.
6. The method of claim 5 , wherein measurement of the intensity of the light re-emitted from the examination area of the tissue sample is obtained by capturing images in successive time points, each image having a plurality of pixels, each pixel being associated with the intensity of the light re-emitted from the examination area of the tissue sample at a spatial point on the tissue under examination.
7. The method of claim 5 , wherein each of the two or more narrower spectral bands are recorded simultaneously in different areas of a detector attached to the optical head.
8. The method of claim 1 , wherein the examination area of the tissue sample is exposed to polarized light.
9. The method of claim 1 , further comprising the step of polarizing light re-emitted from the examination area of the tissue sample in a direction perpendicular to the direction of polarization of the light to which the tissue sample is exposed.
10. The method of claim 1 , further comprising the step of synchronizing the administering the pathology differentiating agent and the measuring of the intensity of the light re-emitted.
11. The method of claim 1 , wherein said pathology differentiating agent is selected from a group of acidic and basic solutions.
12. The method of claim 11 , wherein the acidic solution is an acetic acid solution.
13. The method of claim 1 further comprising the step of, representing the image by a scale of pseudo-colors.
14. The method of claim 13 further comprising the step of, superimposing the pseudo-color represented image on an image of the examination area of the tissue sample.
15. The method of claim 14 , wherein the step of superimposing occurs in real time.
16. The method of claim 13 , wherein said pseudo-color represented image comprises a map depicting the spatial distribution of correlation degree between the intensity and the extent of the provoked alterations with a pathology and a stage of a tissue lesion.
17. The method of claim 1 , wherein the tissue sample is selected from the group consisting of a cervix, a larynx, and an oral cavity.